U.S. FDA narrows patient group for Biogen's Alzheimer's drug
July 8 (Reuters) - Biogen Inc said the U.S. drug regulator has narrowed the patient group that can u
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial